Home > Animal Health & Nutrition > Veterinary Medical Devices > Veterinary Molecular Diagnostics Market
Veterinary Molecular Diagnostics Market size was valued at USD 298 million in 2022 and is anticipated to reach USD 678.8 million by 2032 at CAGR of 8.6%. Some of the major factors including rising adoption of companion animals, high prevalence of zoonotic and foodborne diseases, technological advancements in veterinary molecular diagnostic technologies, and increasing adoption of pet insurance.
The veterinary molecular diagnostics refers to the use of molecular techniques such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray, to diagnose infectious diseases, genetic disorders, and other conditions in animals. The industry includes the products used for the analysis of animal DNA, RNA, and proteins to identify specific nucleic acid sequences or mutations associated with disease or predisposition to disease. These diagnostic tests are performed in diagnostic laboratories, veterinary hospitals & clinics, research institutions, and other animal care facilities to aid in the accurate diagnosis, treatment, and prevention of diseases in animals.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Veterinary Molecular Diagnostics Market Size in 2022: | USD 298 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8.6% |
2032 Value Projection: | USD 678.8 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 313 |
Tables, Charts & Figures: | 539 |
Segments covered: | Product, Technology, Application, Animal Type, End-user, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|